153 related articles for article (PubMed ID: 32656784)
1. Successful treatment with i.v. immunoglobulin and rituximab for bronchiolitis obliterans associated with paraneoplastic pemphigus.
Kaibuchi-Ando K; Sugiura K; Muro Y; Takahashi Y; Kojima S; Ishii N; Hashimoto T; Akiyama M
J Dermatol; 2020 Oct; 47(10):e368-e370. PubMed ID: 32656784
[No Abstract] [Full Text] [Related]
2. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
Namba C; Tohyama M; Hanakawa Y; Murakami M; Shirakata Y; Matsumoto T; Suemori K; Ishii N; Hashimoto T; Sayama K
J Dermatol; 2016 Apr; 43(4):419-22. PubMed ID: 26506947
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic pemphigus with bronchiolitis obliterans in a child.
Mar WA; Glaesser R; Struble K; Stephens-Groff S; Bangert J; Hansen RC
Pediatr Dermatol; 2003; 20(3):238-42. PubMed ID: 12787274
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic Pemphigus. A Life-Threatening Autoimmune Blistering Disease.
Tirado-Sánchez A; Bonifaz A
Actas Dermosifiliogr; 2017 Dec; 108(10):902-910. PubMed ID: 28801011
[TBL] [Abstract][Full Text] [Related]
5. Constrictive bronchiolitis obliterans and paraneoplastic pemphigus.
Hasegawa Y; Shimokata K; Ichiyama S; Saito H
Eur Respir J; 1999 Apr; 13(4):934-7. PubMed ID: 10362065
[TBL] [Abstract][Full Text] [Related]
6. Bronchiolitis Obliterans With Anti-Epiplakin Antibodies in a Boy With Paraneoplastic Pemphigus.
Rivas-Calderon M; Yamazaki-Nakashimada MA; Orozco-Covarrubias L; Durán-McKinster C; Pacheco-Tovar D; Ávalos-Díaz E; Sáez-de-Ocariz M
Pediatrics; 2022 Mar; 149(3):. PubMed ID: 35118492
[TBL] [Abstract][Full Text] [Related]
7. Therapy of paraneoplastic pemphigus with Rituximab: A case report.
Zhang H; Hu B; Chen H; Wan L; Chen J; Zhou X; Chen L
Dermatol Ther; 2021 Nov; 34(6):e15144. PubMed ID: 34582076
[TBL] [Abstract][Full Text] [Related]
8. [Factors associated with long-term survival in critically ill patients following surgery for solid tumors complicated with paraneoplastic pemphigus].
Pan JX; Zhu SN; Li SL; Wang DX
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):981-990. PubMed ID: 36241242
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans.
Chorzelski T; Hashimoto T; Maciejewska B; Amagai M; Anhalt GJ; Jablonska S
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):393-400. PubMed ID: 10459112
[TBL] [Abstract][Full Text] [Related]
10. A case in which paraneoplastic pemphigus and bronchiolitis obliterans are the main manifestations of inflammatory pseudotumour-like follicular dendritic cell sarcoma.
Zhao C
Australas J Dermatol; 2020 Aug; 61(3):e376-e377. PubMed ID: 32319082
[No Abstract] [Full Text] [Related]
11. Paraneoplastic pemphigus occurs most commonly in indolent B cell lymphoma.
Morikawa K; Tsuji T; Yamasaki H; Egashira S; Kaguchi A; Kido M; Tsuda H
Acta Haematol; 2014; 132(1):73-4. PubMed ID: 24481059
[No Abstract] [Full Text] [Related]
12. Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy.
Lee S; Yamauchi T; Ishii N; Hashimoto T; Kinoshita K; Imamura S; Kamiya K
Int J Hematol; 2017 Dec; 106(6):852-859. PubMed ID: 28791608
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of paraneoplastic pemphigus and bronchiolitis obliterans associated with follicular lymphoma with obinutuzumab and bendamustine.
Kuriyama K; Kitamura Y; Tsuji T; Nishikawa R; Nagata H; Ohshiro M; Sugitani M; Hirakawa Y; Matsumoto Y; Iwai T; Uchiyama H
Curr Probl Cancer; 2022 Apr; 46(2):100813. PubMed ID: 34844771
[TBL] [Abstract][Full Text] [Related]
14. A middle-aged man presenting with unexplained mucosal erosions and progressive dyspnoea.
Healy WJ; Peters S; Nana-Sinkam SP
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25953579
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) in a child: case report and review of the literature.
Lane JE; Woody C; Davis LS; Guill MF; Jerath RS
Pediatrics; 2004 Oct; 114(4):e513-6. PubMed ID: 15466078
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus.
Kikuchi T; Mori T; Shimizu T; Koda Y; Abe R; Kurihara Y; Funakoshi T; Yamagami J; Sato H; Tsunoda K; Amagai M; Okamoto S
Ann Hematol; 2017 Jul; 96(7):1221-1222. PubMed ID: 28447163
[No Abstract] [Full Text] [Related]
17. CD8+ T lymphocytes in bronchiolitis obliterans, paraneoplastic pemphigus, and solitary Castleman's disease.
Hoffman MA; Qiao X; Anhalt GJ
N Engl J Med; 2003 Jul; 349(4):407-8. PubMed ID: 12878753
[No Abstract] [Full Text] [Related]
18. Bronchiolitis obliterans, Castleman's disease, and a bullous disease: pemphigus vulgaris or paraneoplastic pemphigus?
Pizarro A; García-Tobaruela A; Pinilla J
Hum Pathol; 1998 Jun; 29(6):657-8. PubMed ID: 9635692
[No Abstract] [Full Text] [Related]
19. Bronchiolitis obliterans presenting as prolonged ventilator dependence in a patient with paraneoplastic pemphigus.
Saito S; Sanui M; Fujii T; Endo A; Saito K; Iwai K; Uchino S; Takinawi M
Anaesth Intensive Care; 2012 Jul; 40(4):726-8. PubMed ID: 22813514
[No Abstract] [Full Text] [Related]
20. [Follicular lymphoma accompanied by paraneoplastic pemphigus and bronchiolitis obliterans: a case report].
Watanabe K; Yoshifuji K; Saito T; Yamashita T; Nogami A; Sakashita C; Fukuda T; Arai A; Tohda S; Kawamata N; Miura O; Yamamoto M
Rinsho Ketsueki; 2019; 60(1):7-11. PubMed ID: 30726827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
